Neha Korde, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Neha Korde, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:44 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07099391 · A Study of Dara-RVd and Teclistamab-RVd in People With Multiple MyelomaMemorial Sloan Kettering Cancer Center · recruiting · Multiple Myeloma · principal investigator
- N/ANCT04221178 · Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative RemissionMemorial Sloan Kettering Cancer Center · active not recruiting · Plasma Cell Myeloma · principal investigator
- Ph2NCT03290950 · A Study of Daratumumab in Patients With Newly Diagnosed Multiple MyelomaMemorial Sloan Kettering Cancer Center · active not recruiting · Multiple Myeloma · principal investigator
- N/ANCT03006315 · Mobile Health Device Study for Myeloma PatientsMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma, Myeloma · principal investigator
- Ph1/Ph2NCT02937571 · High Dose Carfilzomib for Newly Diagnosed MyelomaMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.